Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (261-270 of 308) with videos related to

Pageof 31
Sort By:
The American Journal of Medicine|March 14, 2007
Gaps in treatment among users of osteoporosis medications: the dynamics of noncomplianceM Alan Brookhart, Jerry Avorn, Jeffrey N Katz, et al.
JAMA Network Open|May 17, 2022
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020Mayookha Mitra-Majumdar, Simon J Gunter, Aaron S Kesselheim, et al.
Plos One|October 22, 2016
Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalAaron S Kesselheim, Wesley Eddings, Tara Raj, et al.
International Quarterly of Community Health Education|September 2, 2009
High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in PennsylvaniaJennifer M Polinski, Suzanne M Cadarette, Marilyn Arnold, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 6, 2006
Assessing health state utilities in elderly patients at cardiovascular riskWolfgang C Winkelmayer, Joshua S Benner, Robert J Glynn, et al.
The New England Journal of Medicine|September 21, 2012
A randomized study of how physicians interpret research funding disclosuresAaron S Kesselheim, Christopher T Robertson, Jessica A Myers, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick, William H Shrank, Robert J Glynn, et al.
Medical Care|November 6, 2009
Patient, physician, and payment predictors of statin adherenceDavid C Chan, William H Shrank, David Cutler, et al.
Drug Safety|July 15, 2019
Multimodal Analysis of FDA Drug Safety Communications: Lessons from ZolpidemAaron S Kesselheim, Michael S Sinha, Eric G Campbell, et al.
Epilepsy & Behavior : E&B|September 21, 2015
Comparative effectiveness of generic versus brand-name antiepileptic medicationsJoshua J Gagne, Aaron S Kesselheim, Niteesh K Choudhry, et al.
Pageof 31

Showing results (261-270 of 308) with videos related to

Sort By:
Pageof 31
The American Journal of Medicine|March 14, 2007
Gaps in treatment among users of osteoporosis medications: the dynamics of noncomplianceM Alan Brookhart, Jerry Avorn, Jeffrey N Katz, et al.
JAMA Network Open|May 17, 2022
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020Mayookha Mitra-Majumdar, Simon J Gunter, Aaron S Kesselheim, et al.
Plos One|October 22, 2016
Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalAaron S Kesselheim, Wesley Eddings, Tara Raj, et al.
International Quarterly of Community Health Education|September 2, 2009
High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in PennsylvaniaJennifer M Polinski, Suzanne M Cadarette, Marilyn Arnold, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 6, 2006
Assessing health state utilities in elderly patients at cardiovascular riskWolfgang C Winkelmayer, Joshua S Benner, Robert J Glynn, et al.
The New England Journal of Medicine|September 21, 2012
A randomized study of how physicians interpret research funding disclosuresAaron S Kesselheim, Christopher T Robertson, Jessica A Myers, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick, William H Shrank, Robert J Glynn, et al.
Medical Care|November 6, 2009
Patient, physician, and payment predictors of statin adherenceDavid C Chan, William H Shrank, David Cutler, et al.
Drug Safety|July 15, 2019
Multimodal Analysis of FDA Drug Safety Communications: Lessons from ZolpidemAaron S Kesselheim, Michael S Sinha, Eric G Campbell, et al.
Epilepsy & Behavior : E&B|September 21, 2015
Comparative effectiveness of generic versus brand-name antiepileptic medicationsJoshua J Gagne, Aaron S Kesselheim, Niteesh K Choudhry, et al.
Pageof 31